Ironwood Pharmaceuticals Inc (IRWD)
Financial leverage ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 471,073 | 524,063 | 603,220 | 1,155,280 | 1,100,520 | 1,040,340 | 975,690 | 1,083,380 | 1,126,930 | 1,079,370 | 1,007,220 | 599,344 | 559,238 | 492,324 | 443,538 | 404,005 | 402,748 | 334,343 | 315,721 | 363,538 |
Total stockholders’ equity | US$ in thousands | -346,295 | -323,216 | -345,704 | 706,852 | 652,378 | 591,063 | 532,883 | 517,783 | 605,911 | 579,941 | 511,756 | 110,192 | 62,640 | 5,904 | -36,852 | -71,557 | -93,251 | -153,047 | -219,367 | -237,179 |
Financial leverage ratio | — | — | — | 1.63 | 1.69 | 1.76 | 1.83 | 2.09 | 1.86 | 1.86 | 1.97 | 5.44 | 8.93 | 83.39 | — | — | — | — | — | — |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $471,073K ÷ $-346,295K
= —
The financial leverage ratio of Ironwood Pharmaceuticals Inc has been gradually decreasing over the past quarters, indicating a trend towards lower financial leverage. The ratio was 2.09 in Q1 2022, which means that for every dollar of equity, the company had $2.09 of debt. This high ratio suggests a higher level of debt relative to equity in the company's capital structure.
However, there has been a consistent decrease in the financial leverage ratio since then, reaching 1.63 in Q1 2023. This decrease indicates that the company may be reducing its reliance on debt financing and strengthening its equity position. A lower financial leverage ratio generally signifies a more conservative capital structure, potentially reducing financial risk and improving the company's financial stability.
Overall, the decreasing trend in the financial leverage ratio of Ironwood Pharmaceuticals Inc suggests a positive shift towards a more balanced and sustainable capital structure. It is essential for investors and stakeholders to monitor this ratio to assess the company's ability to meet its financial obligations and manage risks effectively.
Peer comparison
Dec 31, 2023